Volume 26, Issue 3 (May-June 2021)

OPINION ARTICLE

Predicting outcomes of surgical management of intrahepatic cholangiocarcinoma: A Gordian Knot
Dimitrios Moris, Georgia-Sofia Karachaliou, Panagiotis Sakarellos, Nikolaos Dimitrokallis; pp 648-653 (Pubmed Abstract, PDF)

SPECIAL ARTICLE

The COVID-19 survey pandemic: a critical approach
Marios Adamou, Konstantinos Kamposioras; pp 654-655 (Pubmed Abstract, PDF)

ORIGINAL ARTICLES

GYNECOLOGIC CANCER

Clinical analysis of uterine arterial interventional chemoembolization combined with radiotherapy in mid-advanced cervical cancer
Dilinaer Aishanjiang, Lili Han, Mayinuer Niyazi, Qingxiang Hou; pp 656-662 (Pubmed Abstract, PDF)

Clinical significance of miR-139-5p and FGF2 in ovarian cancer
Meijuan Wang, Xinmei Mao, Shuying Wang; pp 663-669 (Pubmed Abstract, PDF)

Comparative study of BRAF gene mutations in ovarian serous tumors by immunohistochemistry and DNA sequencing
Yi-Yao Liu, Qing-Ping Wang, Fang-Fang Liu, Hui-Ting Zhu, Qi-Zhi He; pp 670-676 (Pubmed Abstract, PDF)

MicroRNA-186-5p inhibits the metastasis of cervical cancer by targeting FZD3
Ao Wang, Ying Wang, Jun Zhan, Jie Chen; pp 677-683 (Pubmed Abstract, PDF)

Curative effect of laparoscopic-assisted vaginal radical trachelectomy combined with pelvic lymph node dissection on early-stage cervical cancer
Ying Wang, Ao Wang, Jun Zhan, Tao Guo; pp 684-690 (Pubmed Abstract, PDF)

CircHIPK3 modulates VEGF through MiR-7 to affect ovarian cancer cell proliferation and apoptosis
Heling Zhou, Jie Li, Xiaoli Lai, Kai Wang, Wei Zhou, Jun Wang; pp 691-697 (Pubmed Abstract, PDF)

Long-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary application in cervical cancer
Ebru Atasever Akkas, Muzzafer Bedri Altundag; pp 698-706 (Pubmed Abstract, PDF)

Human papillomavirus in breast cancer of patients with cervical intraepithelial neoplasia or cervical cancer history. A systematic review and meta-analysis
Evangelia Mareti, Christos Chatzakis, Georgios-Chrysostomos Pratilas, Anastasios Liberis, Eleftherios Vavoulidis, Anastasios Papanastasiou, Roxani Dampali, Angelos Daniilidis, Leonidas Zepiridis, Konstantinos Dinas; pp 707-713 (Pubmed Abstract, PDF)

BREAST CANCER

Cardiac safety of neoadjuvant chemotherapy with epirubicin and cyclophosphamide followed by docetaxel/pertuzumab/trastuzumab for HER2-positive breast cancer patients
George Douganiotis, Savvas Grigoriadis, Loukas Kontovinis, Efrosini Markopoulou, Athanasios Pouptsis, Konstantinos Papazisis; pp 714-719 (Pubmed Abstract, PDF)

Advancement study of CancerMath model as prognostic tools for predicting Sentinel lymph node metastasis in clinically negative T1 breast cancer patients
Raffaella Massafra, Domenico Pomarico, Annarita Fanizzi, Francesco Campobasso, Vittorio Didonna, Agnese Latorre, Annalisa Nardone, Irene Maria Pastena, Pasquale Tamborra,Vito Lorusso, Daniele La Forgia; pp 720-727 (Pubmed Abstract, PDF)

Expression and clinical significance of lncRNA-SChLAP1 in breast cancer
Sixian Cheng, Qingquan Zhao, Zhengrong Zheng; pp 728-733 (Pubmed Abstract, PDF)

Capecitabine metronomic chemotherapy combined with autologous CIK cell immunotherapy in the treatment of recurrent and metastatic triple-negative breast cancer
Sipan Chen, Yaobo Yang, Yang Jiao, Hua Sun, Zhaoyong Yan; pp 734-740 (Pubmed Abstract, PDF)

Association between gene polymorphism of GRK5 and breast cancer risk in Chinese population
Binbin Wu, Tiaosi Xing, Huixin Li, Waner He, Bojian Li; pp 741-746 (Pubmed Abstract, PDF)

Investigation of somatic PIK3CA gene mutations in breast cancer patients
Alina M. Pevzner, Ksenia А. Gaptulbarova, Matvey M. Tsyganov, Marina K. Ibragimova, Andrew V. Vvedensky, Yulia G. Zhusina, Denis V. Pyankov, Sergey A. Korostylev, Nikolai V. Litviakov; pp 747-752 (Pubmed Abstract, PDF)

Comparative analysis of the absorbed dose in the heart and anterior descending branch of the left coronary artery (LAD) in patients with left-sided breast cancer who received radiotherapy using 3D-CRT, IMRT and VMAT techniques
Tamara Kuzba-Kryszak, Sławomir Nowakowski, Janusz Winiecki, Roman Makarewicz; pp 753-758 (Pubmed Abstract, PDF)

HEAD & NECK CANCER

Targeting EGFR in nasopharyngeal carcinoma
Efthymios Kyrodimos, Aristeidis Chrysovergis, Nicholas Mastronikolis, Evangelos Tsiambas, Vasileios Ragos, Dimitrios Roukas, Panagiotis Fotiades, Vasileios Papanikolaou; pp 759-761 (Pubmed Abstract, PDF)

Long-chain non-coding RNA HOTTIP enhances oral cancer cell proliferation and migration capacity by down-regulating miR-206
Na Li, Hongbo Dong, Qing Xia, Xuezhen Wang; pp 762-768 (Pubmed Abstract, PDF)

Topoisomerase IIa protein expression analysis in oral squamous cell carcinoma
Vasileios Papanikolaou, Efthymios Kyrodimos, Nicholas Mastronikolis, Evangelos Tsiambas, Vasileios Ragos, Aristeidis Chrysovergis; pp 769-773 (Pubmed Abstract, PDF)

Efficacy of induction chemotherapy combined with chrono-chemotherapy and intensity-modulated radiotherapy on locally advanced nasopharyngeal carcinoma
Song Zhang, Ting Teng, Guihua Liao, Yang Liu, Qingguo Liu, Wei He, Yan Liu; pp 774-780 (Pubmed Abstract, PDF)

Reconstructing carcinoma of the lip commissure and buccal mucosa: an oncosurgical alternative approach
Vasileios Ragos, Aristeidis Chrysovergis, Sofianiki Mastronikoli, Chrissa Sioka, Asimakis Asimakopoulos, Evangelos Giotakis, Evangelos Tsiambas, Athanasios Niotis, Panagiotis Fotiades, Efthymios Kyrodimos, Nicholas Mastronikolis; pp 781-784 (Pubmed Abstract, PDF)

Biological functions of miR-183 on chemosensitivity of laryngeal cancer cells
Guangming Lou, Jinghua Chen, Lizhen Wu, Yongming Yu, Yuyong Huang; pp 785-791 (Pubmed Abstract, PDF)

Determining priority risk groups for compensation of treatment breaks in radical radiotherapy in patients with locally advanced head and neck cancer
Lohynska Radka, Jirkovska Michaela, Novakova-Jiresova Alena, Kratka Zuzana, Malinova Bela; pp 792-801 (Pubmed Abstract, PDF)

LUNG CANCER

AKR1C3 and β-catenin expression in non-small cell lung cancer and relationship with radiation resistance
Wei Xiong, Xiaozhi Huang, Wanning Hu; pp 802-811 (Pubmed Abstract, PDF)

Efficacy of surgery combined with chemoradiotherapy in treating limited-stage small cell lung cancer and prognosis analysis
Wenchao Gu, Xiulan Liu, Xueni Liu, Yahua Zhong; pp 812-818 (Pubmed Abstract, PDF)

The role of adjuvant chemotherapy in resected stage I non – small cell lung cancer: A Turkish Oncology Group Study
Naziye Ak, Berker Ozkan, Mustafa B. Yenigun, Dilek Yilmazbayhan, Alper Toker, Ferhat Ferhatoglu, Arzu Yasar, Serpil Dizbay Sak, Serhan Tanju, Sukru Dilege, Suat Erus, Pinar Bulutay, Pinar Firat, Nil Molinas Mandel, Sadettin Kilickap, Sevgen Onder, Erkan Dikmen, Ozkan Alan, Perran F. Yumuk, Emine Bozkurtlar, Tunc Lacin, Bedrettin Yildizeli, Akin Ozturk, Celalettin Kocaturk, Kemal Karapinar, Nur Urer, Basak Oyan, Adnan Aydiner, Ahmet Demirkazik, Yesim Eralp; pp 819-829 (Pubmed Abstract, PDF)

Zoledronic acid combined with chemotherapy in non-small cell lung cancer with bone metastasis
Jingnan Zhang, Lisha Yu, Jing Guan, Juan Zhang, Yunfang Pan, Mei Wang; pp 830-836 (Pubmed Abstract, PDF)

Curative effect of hyperfractionated accelerated radiotherapy combined with EP chemotherapy regimen on limited-stage small cell lung cancer
Yeru Tan, Qiao Yang, Xiaoping Wu, Hongbo Zhu; pp 837-843 (Pubmed Abstract, PDF)

First-line pembrolizumab efficacy in patients with advanced non-small cell lung cancer: A Bi-center retrospective, real-life experience study
Omer Diker, Polat Olgun; pp 844-852 (Pubmed Abstract, PDF)

Skeletal muscle loss during anti-epidermal growth factor receptor therapy is an independent prognostic factor on non-small cell lung cancer patients survival
Ahmet Kucukarda, Ali Gokyer, İvo Gokmen, Muhammed Bekir Hacioglu, Osman Kostek, Nazmi Kurt, Derya Karabulut, Nermin Tuncbilek, Sernaz Uzunoglu, Bulent Erdogan, Irfan Cicin; pp 853-860 (Pubmed Abstract, PDF)

LIVER CANCER

Nek2B accelerates the progression of hepatocellular carcinoma through regulating SFRP1 to activate the Wnt/β-catenin pathway
Ling Li, Yongan Ye, Yun Ran, Yichi Zhou, Zhibo Dang, Xiaopeng Su, Shiping Hu; pp 861-867 (Pubmed Abstract, PDF)

Efficacy of sorafenib combined with transcatheter hepatic arterial chemoembolization in treating intermediate-advanced hepatocellular carcinoma
Junjie Kuang, Desheng Wan, Peiwen Wan, Dehua Wu; pp 868-874 (Pubmed Abstract, PDF)

Celecoxib enhances apoptosis of the liver cancer cells via regulating ERK/JNK/P38 pathway
Zhe Jia, Haitao Zhang, Chao Ma, Ning Li, Menglong Wang; pp 875-881 (Pubmed Abstract, PDF)

CDCA2 triggers in vivo and in vitro proliferation of hepatocellular carcinoma by activating the AKT/CCND1 signaling
Jiezhou Li, Yangqing Chen, Xiandao Wang, Chan Wang; pp 882-888 (Pubmed Abstract, PDF)

Which is the best combination of surgery for hepatocellular carcinoma with hepatic/portal vein thrombosis in China: a network meta-analysis of randomized controlled trials
Qi-Qiao Wu,Yi-Xing Chen,Ting-Ting Zheng, Meng-Ting Dai, Ting-Ye, Yu-Hong Xu, Yong Hu, Shi-Suo-Du, Zhao-Chong Zeng; pp 889-896 (Pubmed Abstract, PDF)

Efficacy of antiviral therapy in patients with hepatitis B-related primary liver cancer
Xifeng Sun, Xiaoyan Yan, Rongfeng Shao, Feng Pan, Tingting Li, Qinglian Tian; pp 897-903 (Pubmed Abstract, PDF)

GASTRIC CANCER

Two therapeutic regimens for advanced gastric carcinoma: DOS chemotherapy alone vs. trastuzumab combined with DOS
Nan Jiang, Jianyong Chen, Yuan Jin; pp 904-910 (Pubmed Abstract, PDF)

Diagnostic value of multi-slice spiral CT (MSCT) combined with digestive tract angiography in gastric fundus cardia carcinoma
Jian Sun, Yunhui Qu, Na Long, Chao Ran; pp 911-916 (Pubmed Abstract, PDF)

Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer
Hui Chen, Liangjun Xue, Lihong Liu, Pengfei Li; pp 917-923 (Pubmed Abstract, PDF)

Chloroquine enhances catalpol’s ability to promote apoptosis by inhibiting catalpol’s autophagy-promoting effect on gastric cancer
Fangzheng Sun, Zhenghua Wang, Xiaoyu Wang; pp 924-931 (Pubmed Abstract, PDF)

Efficacy of trastuzumab combined with SOX or IP chemotherapy regimen in the treatment of advanced gastric cancer
Dazhou Xu, Zhimei Zhang, Shuxian Zhang, Xinjian Fang, Lei Wang, Qiuling Li; pp 932-939 (Pubmed Abstract, PDF)

PROSTATE CANCER

Image-guided radiation therapy produces lower acute and chronic gastrointestinal and genitourinary toxicity in prostate cancer patients
Jan Stuk, Jaroslav Vanasek, Karel Odrazka, Martin Dolezel, Iveta Kolarova, Ales Hlavka, Martina Vitkova, Zuzana Sinkorova; pp 940-948 (Pubmed Abstract, PDF)

The role of Circ_PRKCI/miR-24-3p in the metastasis of prostate cancer
Min Kong, Haijun Li, Wuliang Yuan, Linhua Mao, Jun Chen; pp 949-955 (Pubmed Abstract, PDF)

Comparative radiobiological analysis and preliminary results of Ultra hypofractionated accelerated radiotherapy for
low-risk prostate cancer patients

Christos Nanos, Vasilios Souftas, Athanasios Zisimopoulos, Ioannis Abatzoglou, Michael I. Koukourakis; pp 956-963 (Pubmed Abstract, PDF)

3D laparoscopic salvage radical prostatectomy: mini-series report and review of the literature
Horia Schitcu Vlad, Mira Florea, Alexandru Marica Nucu, Ioan-Catalin Vlad, Ion Cojocaru, Munteanu Vlad, Paul Kubelac, Mihnea Bogdan Borz; pp 964-969 (Pubmed Abstract, PDF)

CNS TUMORS

Proton re-irradiation of unresectable recurrent brain gliomas: clinical outcomes and toxicity
Igor Gulidov, Konstantin Gordon, Alexey Semenov, Danil Gogolin, Olga Lepilina, Olga Golovanova, Sergey Dujenko, Kira Medvedeva, Sergey Koryakin, Sergey Ivanov, Andrey Kaprin; pp 970-976 (Pubmed Abstract, PDF)

Temozolomide chemotherapy combined with radiotherapy versus radiotherapy alone after surgery in patients with high-risk low-grade gliomas
Yilin Hou, Yu Huan, Yufu Zhang, Xufeng Liu, Yuqian Li; pp 977-983 (Pubmed Abstract, PDF)

LncRNA MALAT1 promotes glioma cell growth through sponge miR-613
Yang Su, Chao Liang, Qunfu Yang; pp 984-991 (Pubmed Abstract, PDF)

COLORECTAL CANCER

The effect of preferentially expressed antigen in melanoma (PRAME) expression status on survival in stage II and stage III colon cancer
Ali Ogul, Semra Paydas, Figen Doran, Kivilcim Eren Erdogan, Mert Tohumcuoglu, Mahmut Buyuksimsek, Cem Mirili, Abdullah Evren Yetisir; pp 992-1001 (Pubmed Abstract, PDF)

Efficacy of transcatheter arterial chemoembolization combined with capecitabine and cetuximab in the treatment of colorectal cancer with liver metastasis
Xiong Yun, Hua Meng, Anfu Zhou, Jingchao Jia, Weiling Qian; pp 1002-1008 (Pubmed Abstract, PDF)

Smoking induces the occurrence of colorectal cancer via changing the intestinal permeability
Huixiong Wang, Xiaoting Chen, Qiang Gao, Kai Liu, Guoshan Bi, Jiangbei Deng, Xin Zhang; pp 1009-1015 (Pubmed Abstract, PDF)

THYROID CANCER

Parvovirus B19 detection analysis in thyroid tissue paired samples: an observational study from a tertiary surgical oncology department
Dimitrios Nasikas, Alexandros Zafiropoulos, Emmanouil K. Symvoulakis, Antonios Bertsias, Stavros Derdas, Demetrios A. Spandidos, Georgios Sakorafas, George Sourvinos; pp 1016-1021 (Pubmed Abstract, PDF)

Clinical analysis of total endoscopic thyroidectomy via breast areola approach in early differentiated thyroid cancer
Yanqing Qu, Yibing Han, Weijiao Wang, Xiaojian Zhang, Guohui Ma; pp 1022-1027 (Pubmed Abstract, PDF)

Efficacy of 131I therapy and its influencing factors in children and adolescents with differentiated thyroid carcinoma
Ming Luo, Yongjun Hu; pp 1028-1033 (Pubmed Abstract, PDF)

BLADDER CANCER

The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment
Ali Gokyer, Ahmet Kucukarda, Osman Kostek, Sezin Sayin, Nuray Can, Bekir Hacıoglu, Bulent Erdogan, Sernaz Uzunoglu, Irfan Cicin; pp 1034-1039 (Pubmed Abstract, PDF)

Association of obesity and other anthropometric characteristics with bladder cancer risk: a systematic review and meta-analysis of longitudinal cohort studies.
Lazaros Tzelves, Dimitra Xenou, Andreas Skolarikos, Ioannis Varkarakis, Charalampos Deliveliotis, Evangelos Terpos, Kimon Stamatelopoulos, Theodoros N. Sergentanis, Theodora Psaltopoulou; pp 1040-1055 (Pubmed Abstract, PDF)

ESOPHAGEAL CANCER

HOTTIP is upregulated in esophageal cancer and triggers the drug resistance
Yimin Li, Yuhu Liu, Guiquan Chen, Huizhu Liu, Yifen Wu, Juan Liu, Zhijian Zhang; pp 1056-1061 (Pubmed Abstract, PDF)

Thoracoscopiclaparoscopic Ivor-Lewis surgery vs. mckeown surgery in treatment of thoracic middle-lower segment esophageal cancer
Yubo Shi, Airu Wang, Shuling Yu, Xiuqu Fei, Shuliang Liu, Jie Liao; pp 1062-1069 (Pubmed Abstract, PDF)

HEMATOLOGIC MALIGNANCIES

Prediction of optimal cytogenetic responses at 6 and 12 months in patients with chronic myeloid leukemia in chronic phase treated with imatinib
Violeta Milosevic, Maja Perunicic Jovanovic, Zoran Bukumirić, Vesna Djordjevic, Jelica Jovanovic, Marija Dencic Fekete, Danijela Lekovic, Andrija Bogdanovic; pp 1070-1079 (Pubmed Abstract, PDF)

Comparison of peripheral blood stem cell mobilization with filgrastim versus pegfilgrastim in lymphoma patients – single center experience
Lavinia Lipan, Andrei Colita, Laura Stefan, Carmen Calugaroiu, Catalin Serban, Ciprian Tomuleasa, Sergiu Pasca, Anca Colita, Alina Tanase; pp 1080-1087 (Pubmed Abstract, PDF)

RENAL CANCER

Is 3D laparoscopic off clamp simple enucleation a feasible alternative for clinical T1 renal tumors? Outcomes from a single center experience
Razvan George Rahota, Dan Valean, Florentin Dobrota, Iulia Andras, Alexandra Cristina Rahota, Teodor Traian Maghiar, Ioan Coman, Nicolae Crisan; pp 1088-1093 (Pubmed Abstract, PDF)

Laparoscopic radical resection for large-volume renal carcinoma: via retroperitoneal or transperitoneal approach?
Huming Yin, Zheng Zhou, Qiuchen Liu, Feng Qiu; pp 1094-1101 (Pubmed Abstract, PDF)

OSTEOSARCOMA

Late effects of osteosarcoma and its treatment in pediatric patients: A single-center experience
Tacyildiz Nurdan, Cakmak Hatice Mine, Unal Emel, Dincaslan Handan, Tanyildiz Gulsah, Sonay Incesoy Ozdemir, Kartal Omer, Yilmaz Yasin, Yildiz Yusuf, Kerem Basarir, Yavuz Gulsan; pp 1102-1110 (Pubmed Abstract, PDF)

PANCREATIC CANCER

Expression of miR-214 in pancreatic cancer and its effect on the biological function of pancreatic cancer cells
Shikang Deng, Junfeng Wang, Jing Xu, Jiao Li, Li Zhang, Yan Jin; pp 1111-1120 (Pubmed Abstract, PDF)

MISCELLANEOUS

Decrease of oncological patients’ hospital visits during Covid-19 pandemic; the experience of a tertiary Romanian centre
Cristina Crisan, Calin Cainap, Andrada Deac, Andrei Havasi, Ovidiu Balacescu, Loredana Balacescu, Ovidiu Bochis, Catalin Vlad, Simona Cainap; pp 1121-1126 (Pubmed Abstract, PDF)

Psychological well-being in cancer outpatients during COVID-19
Daniela Bafunno, Francesca Romito, Fulvia Lagattolla, Vito Antonio Delvino, Carla Minoia, Giacomo Loseto, Miriam Dellino, Attilio Guarini, Annamaria Catino, Michele Montrone, Vito Longo, Pamela Pizzutilo, Domenico Galetta, Francesco Giotta, Agnese Carmela Latorre, Anna Russo, Vito Lorusso, Claudia Cormio; pp 1127-1134 (Pubmed Abstract, PDF)

Effects of Colchicum baytopiorum leaf extract on cytotoxicity and cell death pathways in C-4 I and Vero cell lines
Ozlem Dagdeviren Ozsoylemez, Gul Ozcan; pp 1135-1147 (Pubmed Abstract, PDF)

Tracking the risk factors associated with high-risk cSCC: A 10-year, Two-Institution, Greek study
Emmanoul Dimonitsas, Gregory Champsas, Despoina Kakagia, Spiros D Stavrianos, Sotirios Roussos, Ortansia Doryforou, Foteini Neamonitou, Efthymia Soura, Epameinondas Kostopoulos, Errieta Christofidou, Othon Papadopoulos, Irene Thymara, Nikolaos A. Papadopoulos, Alexandros Stratigos, Penelope Korkolopoulou; pp 1148-1158 (Pubmed Abstract, PDF)

Antioxidant preconditioning attenuates liver ischemia/reperfusion injury after hepatectomy in swine
Doukakis G. Paradellis, Georgios Sotirios D. Panousopoulos, Antonia G. Mathioulaki, Apostolos E. Papalois, Tzortzis N. Nomikos, Stamatios Theocharis, Georgios A. Gkiokas, Nikolaos F. Arkadopoulos; pp 1159-1164 (Pubmed Abstract, PDF)

SHORT COMMUNICATION

Clinico-laboratory pertinences and management of relapsed and refractory chronic myeloid leukemia
Vasile Musteata; pp 1165-1168 (Pubmed Abstract, PDF)

LETTERS TO THE EDITOR

Patient perspective on sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy in HER2-negative breast cancer patients
Kadri Altundag; p 1169 (Pubmed Abstract, PDF)

Microsatellite instability (MSI) markers in thyroid carcinoma
Nicholas Mastronikolis, Aristeidis Chrysovergis, Evangelos Tsiambas, Efthymios Kyrodimos; p 1169 (Pubmed Abstract, PDF)

Adjuvant pertuzumab plus trastuzumab or adjuvant T-DM1; Which is better?
Kadri Altundag; p 1170 (Pubmed Abstract, PDF)

Considerations for the treatment of esophageal cancer during the COVID-19 pandemic
Spyridon Davakis, Michail Karamouzis, Dimitrios Ziogas, Alexandros Charalabopoulos; p 1170 (Pubmed Abstract, PDF)

Sequential anthracycline and weekly paclitaxel might be more effective compared to docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients
Kadri Altundag; p 1171 (Pubmed Abstract, PDF)

VEGF- mediated mechanisms in nasopharyngeal carcinoma
Arezina Manoli, Spyros Katsinis, Sotirios Papouliakos, Evangelos Tsiambas; p 1172 (Pubmed Abstract, PDF)

Pets might reduce side-effects related to chemotherapy in patients with cancer
Halide Aral, Kadri Altundag; p 1173 (Pubmed Abstract, PDF)

Low-dose metronomic eribulin in metastatic breast cancer: Is this real metronomic therapy?
Kadri Altundag; p 1174 (Pubmed Abstract, PDF)

Histologic subtypes in chemotherapy vs. sacituzumab sovitecan groups might affect progression-free and overall survival in metastatic triple-negative breast cancer
Kadri Altundag; pp 1174-1175 (Pubmed Abstract, PDF)

HISTORY OF ONCOLOGY

Melanosis, melanoma, and melanosarcoma: concepts and terms in 19th century ophthalmology
Konstantinos Laios, Spyros N. Michaleas, Marianna Karamanou, George Androutsos; pp 1176-1178 (Pubmed Abstract, PDF)

EXPRESSION OF CONCERN

Kutkoside -an iridoid glycoside- exerts anti-proliferative effects in drug-resistant human oral carcinoma cells by targeting PI3K/AKT signalling pathway, inducing apoptosis and suppressing cell migration and invasion
Jun-Chi Hou, Xiao-Nan Xu; p 1179 (Pubmed Abstract, PDF)

Baicalein suppresses the growth of the human thyroid cancer cells by inducing mitotic catastrophe, apoptosis and autophagy via NF-kB signalling pathway
Shijian Yi, Guowen Liu, Yang Wu, Qiankun Liang, Lanlan Li; p 1180 (Pubmed Abstract, PDF)

Antiproliferative potential of piperine and curcumin in drug-resistant human leukemia cancer cells are mediated via autophagy and apoptosis induction, S-phase cell cycle arrest and inhibition of cell invasion and migration
Ning Li, Shuyun Wen, Guohua Chen, Shijun Wang; p 1181 (Pubmed Abstract, PDF)

The anticancer effects of 7-Methoxyheptaphylline against the human retinoblastoma cells are facilitated via S-phase cell cycle arrest, mitochondrial apoptosis and inhibition of Wnt/β-catenin signaling pathway
Bin Chen, Tao He, Li Wu, Ting Cao, Hongmei Zheng; p 1182 (Pubmed Abstract, PDF)

Antiproliferative activities of auraptenol against drug-resistant human prostate carcinoma cells are mediated via programmed cell death, endogenous ROS production, and targeting the JNK/p38 MAPK signal pathways
Yunli Liu, Xuedong Li, Zhaoyan Chen, Yunhui Chan p 1183 (Pubmed Abstract, PDF)

Heptazoline exerts antiproliferative effects on human melanoma cells by inducing apoptosis, cell cycle arrest and targeting MAPK signalling pathway
Wei Zhou,Ling Zhou,Min Wang,Zeming Liu, Danyang Chen, Liang Guo; p 1184 (Pubmed Abstract, PDF)

MicroRNA-22 regulates the proliferation, drug sensitivity and metastasis of human glioma cells by targeting SNAIL1
Yunqiang Zhang, Lijun Tu, Xiuhong Zhou, Bin Li; p 1185 (Pubmed Abstract, PDF)

MicroRNA-335 inhibits the growth, chemo-sensitivity, and metastasis of human breast cancer cells by targeting MAP3K2
Yajue Wang, Feng Wen; p 1186 (Pubmed Abstract, PDF)

Cinnamolide sesquiterpene lactone suppresses in vitro and in vivo cancer cell growth in cisplatin-resistant human cervical carcinoma cells by inducing mitochondrial mediated apoptosis, caspase activation, loss of MMP and targeting Akt/β-Catenin signaling pathway
Jing Hou, Changli Kan, Yanju Zhu, Yi Zhang, Bingfeng Zhou, Chunli Ren, Jiuyuan Fu, Yanwei Guo, Jinhuan Zhang; p 1187 (Pubmed Abstract, PDF)

Anticancer effects of juglone in OVCAR-3 human ovarian carcinoma are facilitated through programmed cell death, endogenous ROS production, inhibition of cell migration and invasion and cell cycle arrest
Jun-Yu Shi, Zhe-Ren Huang, Hong-Yan Gao, Xiao-Li Xu; p 1188 (Pubmed Abstract, PDF)

Reset link sent!

Link for password reset has been emailed to you. Please check your email.